154 related articles for article (PubMed ID: 37910041)
1. Editorial Comment: Gadolinium-Based Paramagnetic MRI Contrast Agents-Safe and Effective.
Bush CH
AJR Am J Roentgenol; 2023 Nov; ():. PubMed ID: 37910041
[No Abstract] [Full Text] [Related]
2. Editorial Comment: Toward Meeting ACR-ASNR Guidelines for Reducing Gadolinium-Based Contrast Agent Dose in Brain MRI Examinations.
Cousins JP
AJR Am J Roentgenol; 2021 Nov; 217(5):1205. PubMed ID: 34570589
[No Abstract] [Full Text] [Related]
3. Nanoparticle-Based Paramagnetic Contrast Agents for Magnetic Resonance Imaging.
Pellico J; Ellis CM; Davis JJ
Contrast Media Mol Imaging; 2019; 2019():1845637. PubMed ID: 31191182
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific MR contrast agents.
Weinmann HJ; Ebert W; Misselwitz B; Schmitt-Willich H
Eur J Radiol; 2003 Apr; 46(1):33-44. PubMed ID: 12648800
[TBL] [Abstract][Full Text] [Related]
5. Editorial comment from Dr Mori to recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.
Mori H
Int J Urol; 2012 Sep; 19(9):812. PubMed ID: 22616755
[No Abstract] [Full Text] [Related]
6. Editorial comment from Dr Ishii to recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.
Ishii T
Int J Urol; 2012 Sep; 19(9):811. PubMed ID: 22616727
[No Abstract] [Full Text] [Related]
7. Optimization of gadolinium-based MRI contrast agents for high magnetic-field applications.
Helm L
Future Med Chem; 2010 Mar; 2(3):385-96. PubMed ID: 21426173
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium-labeled liposomes containing paramagnetic amphipathic agents: targeted MRI contrast agents for the liver.
Kabalka GW; Buonocore E; Hubner K; Davis M; Huang L
Magn Reson Med; 1988 Sep; 8(1):89-95. PubMed ID: 3173073
[TBL] [Abstract][Full Text] [Related]
9. Paramagnetic oil emulsions as oral magnetic resonance imaging contrast agents.
Li KC; Ang PG; Tart RP; Storm BL; Rolfes R; Ho-Tai PC
Magn Reson Imaging; 1990; 8(5):589-98. PubMed ID: 2082129
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium-Based Contrast Agent Use, Their Safety, and Practice Evolution.
Do C; DeAguero J; Brearley A; Trejo X; Howard T; Escobar GP; Wagner B
Kidney360; 2020 Jun; 1(6):561-568. PubMed ID: 34423308
[TBL] [Abstract][Full Text] [Related]
11. Gd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents.
Datta A; Raymond KN
Acc Chem Res; 2009 Jul; 42(7):938-47. PubMed ID: 19505089
[TBL] [Abstract][Full Text] [Related]
12. Editorial Comment: Gadolinium-Based Contrast Agent and the Central Vein Sign.
Rubinstein D
AJR Am J Roentgenol; 2023 Jan; 220(1):125. PubMed ID: 36069490
[No Abstract] [Full Text] [Related]
13. Highly hydrated paramagnetic amorphous calcium carbonate nanoclusters as an MRI contrast agent.
Dong L; Xu YJ; Sui C; Zhao Y; Mao LB; Gebauer D; Rosenberg R; Avaro J; Wu YD; Gao HL; Pan Z; Wen HQ; Yan X; Li F; Lu Y; Cölfen H; Yu SH
Nat Commun; 2022 Aug; 13(1):5088. PubMed ID: 36038532
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of a gadolinium based-macrocyclic MRI contrast agent for effective cancer diagnosis.
Jeong Y; Na K
Biomater Res; 2018; 22():17. PubMed ID: 29942642
[TBL] [Abstract][Full Text] [Related]
15. Dendrimer-based nanosized MRI contrast agents.
Kobayashi H; Brechbiel MW
Curr Pharm Biotechnol; 2004 Dec; 5(6):539-49. PubMed ID: 15579043
[TBL] [Abstract][Full Text] [Related]
16. Paramagnetic inorganic nanoparticles as T1 MRI contrast agents.
Lee SH; Kim BH; Na HB; Hyeon T
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(2):196-209. PubMed ID: 24123961
[TBL] [Abstract][Full Text] [Related]
17. Paramagnetic nanoparticles as potential MRI contrast agents: characterization, NMR relaxation, simulations and theory.
Vuong QL; Van Doorslaer S; Bridot JL; Argante C; Alejandro G; Hermann R; Disch S; Mattea C; Stapf S; Gossuin Y
MAGMA; 2012 Dec; 25(6):467-78. PubMed ID: 22790646
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
